A recent study led by Harvard researchers didn’t show meaningful improvement in men with low testosterone. Results from the study beg the question “Why are men with low testosterone being…
Read More
Invokana has been a familiar subject in US Food and Drug Administration (FDA) safety releases as of late. In the past year, the FDA issued safety updates on Invokana and…
Read More
As of July 2016, there are over 700 Inferior Vena Cava (IVC) filter lawsuits pending in a federal court in Arizona. The multidistrict litigation (MDL) is IN RE: Bard IVC…
Read More
Ethicon, a branch of Johnson & Johnson, failed to disclose the dangers and complications linked to its Prosima vaginal mesh device. These statements were given by experts in Texas State…
Read More
Profit maximization—that was the driving force of a pharmaceutical company’s marketing campaign. Not patient health maximization. The primary concern of GlaxoSmithKline (GSK) in one of their sales campaigns rested in…
Read More
On January 4, 2016, the US Food and Drug Administration (FDA) announced a big change for transvaginal mesh. Previously classified as a Class II medical device, the FDA reclassified transvaginal…
Read More
People with Type 2 diabetes take Invokana, or the version with metformin—Invokamet, to regulate blood sugar levels. Treating Type 2 diabetes with medication, along with improved diet and exercise, is…
Read More
A study published in early March by a team of Australian researchers establishes a strong link between Topamax and congenital birth defects. The study was conducted by the Department of…
Read More
There is a strong link between the use of Topamax by pregnant women and the development of a cleft lip or a cleft palate in their unborn child. Quite often,…
Read More
The Pennsylvania jury in a Topamax birth defect lawsuit concluded that Janssen Pharmaceuticals, the maker of Topamax, is to pay the plaintiff in the case an $11 million compensation package.…
Read More